IBDEI0DD ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6384,0)
 ;;=253.4^^44^514^3
 ;;^UTILITY(U,$J,358.3,6384,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6384,1,4,0)
 ;;=4^ANTER PITUITARY DIS NEC
 ;;^UTILITY(U,$J,358.3,6384,1,5,0)
 ;;=5^253.4
 ;;^UTILITY(U,$J,358.3,6384,2)
 ;;=^267862
 ;;^UTILITY(U,$J,358.3,6385,0)
 ;;=258.9^^44^514^17
 ;;^UTILITY(U,$J,358.3,6385,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6385,1,4,0)
 ;;=4^POLYGLANDUL DYSFUNC NOS
 ;;^UTILITY(U,$J,358.3,6385,1,5,0)
 ;;=5^258.9
 ;;^UTILITY(U,$J,358.3,6385,2)
 ;;=^267894
 ;;^UTILITY(U,$J,358.3,6386,0)
 ;;=258.1^^44^514^18
 ;;^UTILITY(U,$J,358.3,6386,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6386,1,4,0)
 ;;=4^POLYGLANDULAR FAILURE
 ;;^UTILITY(U,$J,358.3,6386,1,5,0)
 ;;=5^258.1
 ;;^UTILITY(U,$J,358.3,6386,2)
 ;;=^267892
 ;;^UTILITY(U,$J,358.3,6387,0)
 ;;=626.0^^44^514^1
 ;;^UTILITY(U,$J,358.3,6387,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6387,1,4,0)
 ;;=4^AMENORRHEA
 ;;^UTILITY(U,$J,358.3,6387,1,5,0)
 ;;=5^626.0
 ;;^UTILITY(U,$J,358.3,6387,2)
 ;;=^5871
 ;;^UTILITY(U,$J,358.3,6388,0)
 ;;=628.0^^44^514^2
 ;;^UTILITY(U,$J,358.3,6388,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6388,1,4,0)
 ;;=4^ANOVULATION,INFERTILITY
 ;;^UTILITY(U,$J,358.3,6388,1,5,0)
 ;;=5^628.0
 ;;^UTILITY(U,$J,358.3,6388,2)
 ;;=^270583
 ;;^UTILITY(U,$J,358.3,6389,0)
 ;;=626.5^^44^514^15
 ;;^UTILITY(U,$J,358.3,6389,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6389,1,4,0)
 ;;=4^OVULATION BLEEDING
 ;;^UTILITY(U,$J,358.3,6389,1,5,0)
 ;;=5^626.5
 ;;^UTILITY(U,$J,358.3,6389,2)
 ;;=^270570
 ;;^UTILITY(U,$J,358.3,6390,0)
 ;;=627.1^^44^514^19
 ;;^UTILITY(U,$J,358.3,6390,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6390,1,4,0)
 ;;=4^POSTMENOPAUSAL BLEEDING
 ;;^UTILITY(U,$J,358.3,6390,1,5,0)
 ;;=5^627.1
 ;;^UTILITY(U,$J,358.3,6390,2)
 ;;=^97040
 ;;^UTILITY(U,$J,358.3,6391,0)
 ;;=617.9^^44^514^5
 ;;^UTILITY(U,$J,358.3,6391,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6391,1,4,0)
 ;;=4^ENDOMETRIOSIS NOS
 ;;^UTILITY(U,$J,358.3,6391,1,5,0)
 ;;=5^617.9
 ;;^UTILITY(U,$J,358.3,6391,2)
 ;;=^40463
 ;;^UTILITY(U,$J,358.3,6392,0)
 ;;=628.9^^44^514^6
 ;;^UTILITY(U,$J,358.3,6392,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6392,1,4,0)
 ;;=4^FEMALE INFERTILITY NOS
 ;;^UTILITY(U,$J,358.3,6392,1,5,0)
 ;;=5^628.9
 ;;^UTILITY(U,$J,358.3,6392,2)
 ;;=^62820
 ;;^UTILITY(U,$J,358.3,6393,0)
 ;;=611.6^^44^514^7
 ;;^UTILITY(U,$J,358.3,6393,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6393,1,4,0)
 ;;=4^GALACTORRHEA-NONOBSTET
 ;;^UTILITY(U,$J,358.3,6393,1,5,0)
 ;;=5^611.6
 ;;^UTILITY(U,$J,358.3,6393,2)
 ;;=^270460
 ;;^UTILITY(U,$J,358.3,6394,0)
 ;;=256.1^^44^514^14
 ;;^UTILITY(U,$J,358.3,6394,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6394,1,4,0)
 ;;=4^OVARIAN HYPERFUNC NEC
 ;;^UTILITY(U,$J,358.3,6394,1,5,0)
 ;;=5^256.1
 ;;^UTILITY(U,$J,358.3,6394,2)
 ;;=^267878
 ;;^UTILITY(U,$J,358.3,6395,0)
 ;;=704.1^^44^514^9
 ;;^UTILITY(U,$J,358.3,6395,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6395,1,4,0)
 ;;=4^HIRSUTISM
 ;;^UTILITY(U,$J,358.3,6395,1,5,0)
 ;;=5^704.1
 ;;^UTILITY(U,$J,358.3,6395,2)
 ;;=^57407
 ;;^UTILITY(U,$J,358.3,6396,0)
 ;;=627.2^^44^514^11
 ;;^UTILITY(U,$J,358.3,6396,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6396,1,4,0)
 ;;=4^MENOPAUSE
 ;;^UTILITY(U,$J,358.3,6396,1,5,0)
 ;;=5^627.2
 ;;^UTILITY(U,$J,358.3,6396,2)
 ;;=^328735
 ;;^UTILITY(U,$J,358.3,6397,0)
 ;;=256.31^^44^514^10
 ;;^UTILITY(U,$J,358.3,6397,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6397,1,4,0)
 ;;=4^MANOPAUSE,PREMATURE
 ;;^UTILITY(U,$J,358.3,6397,1,5,0)
 ;;=5^256.31
 ;;^UTILITY(U,$J,358.3,6397,2)
 ;;=^75883
 ;;^UTILITY(U,$J,358.3,6398,0)
 ;;=256.39^^44^514^12
